Myeloperoxidase modulation by LDL apheresis in Familial Hypercholesterolemia

BACKGROUND: Myeloperoxidase (MPO) is a marker of plaque vulnerability and a mechanistic bridge between inflammation and cardiovascular disease, and thus is a suitable target for therapeutic strategy against cardiovascular disease. METHODS: Since hypercholesterolemia is associated with atherosclerosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Puntoni, Mariarita, Sbrana, Francesco, Bigazzi, Federico, Minichilli, Fabrizio, Ferdeghini, Ezio, Sampietro, Tiziana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213072/
https://www.ncbi.nlm.nih.gov/pubmed/22014237
http://dx.doi.org/10.1186/1476-511X-10-185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213072/
https://www.ncbi.nlm.nih.gov/pubmed/22014237
http://dx.doi.org/10.1186/1476-511X-10-185

Ejemplares similares